Fan, Bin
Abou-Alfa, Ghassan K.
Zhu, Andrew X.
Pandya, Shuchi S.
Jia, Hongxia
Yin, Feng
Gliser, Camelia
Hua, Zhaowei
Hossain, Mohammad http://orcid.org/0000-0002-9147-7917
Yang, Hua
Clinical trials referenced in this document:
Documents that mention this clinical trial
Pharmacokinetics/pharmacodynamics of ivosidenib in advanced IDH1-mutant cholangiocarcinoma: findings from the phase III ClarIDHy study
https://doi.org/10.1007/s00280-023-04633-5
Funding for this research was provided by:
Agios Pharmaceuticals
Article History
Received: 23 October 2023
Accepted: 18 December 2023
First Online: 27 January 2024
Declarations
:
: BF, FY, and HY were employees and stockholders of Agios Pharmaceuticals, Inc., at the time of the study. GKA has received research grant/funding from Arcus, AstraZeneca, BioNtech, Bristol Myers Squibb, Celgene, Flatiron, Genentech/Roche, Genoscience, Incyte, Polaris, Puma, QED, Silenseed, and Yiviva; and serves as a consultant for Adicet, Alnylam, AstraZeneca, Autem, Beigene, Berry Genomics, Boehringer Ingelheim, Celgene, Cend, CytomX, Eisai, Eli Lilly, Exelixis, Flatiron, Genentech/Roche, Genoscience, Helio, Helsinn, Incyte, Ipsen, Merck, Nerviano, Newbridge, Novartis, QED, Rafael, Redhill, Servier, Silenseed, Sobi, Vector, and Yiviva. AXZ is an employee of I-Mab Biopharma; has participated in advisory boards for AstraZeneca, Bayer, Bristol Myers Squibb, Eisai, Eli Lilly, Exelixis, Merck, Novartis, and Roche/Genentech; and has received research grant/funding from Bayer, Bristol Myers Squibb, Eli Lilly, Merck, and Novartis. SSP, CG, and MH were employees and stockholders of Agios Pharmaceuticals, Inc., at the time of the study, and are now employees of Servier Pharmaceuticals LLC. HJ was an employee and stockholder of Agios Pharmaceuticals, Inc., at the time of the study, and is now employee of Takeda Pharmaceutical Company Ltd. ZH is an employee of Servier Pharmaceuticals LLC.
: This study was conducted according to the International Council for Harmonisation of Good Clinical Practice guidelines and the principles of the Declaration of Helsinki. Approval from the institutional review board and independent ethics committee was obtained by all study investigators. Informed consent was obtained from all patients included in the study.